2200 TOPGEAR: A randomized phase M/MI trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer. Interim results from an international, intergroup trial of the AGITG/TROG/NCIC CTG/EORTC. Issue 3 (September 2015) - Leong, T.; Smithers, B.M.; Michael, M.; Gebski, V.; Simes, J.; Boussioutas, A.; Miller, D.; Zalcberg, J.; O'Connell, R.; Swallow, C.; Darling, G.; Wong, R.; et al.